Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Change in Cash (2016 - 2025)

Historic Change in Cash for vTv Therapeutics (VTVT) over the last 12 years, with Q3 2025 value amounting to $72.6 million.

  • vTv Therapeutics' Change in Cash rose 193519.6% to $72.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.9 million, marking a year-over-year increase of 7080.07%. This contributed to the annual value of $27.3 million for FY2024, which is 111865.67% up from last year.
  • As of Q3 2025, vTv Therapeutics' Change in Cash stood at $72.6 million, which was up 193519.6% from -$5.1 million recorded in Q2 2025.
  • Over the past 5 years, vTv Therapeutics' Change in Cash peaked at $72.6 million during Q3 2025, and registered a low of -$6.7 million during Q2 2024.
  • Moreover, its 5-year median value for Change in Cash was -$2.5 million (2022), whereas its average is $4.9 million.
  • In the last 5 years, vTv Therapeutics' Change in Cash plummeted by 49942.05% in 2024 and then soared by 193519.6% in 2025.
  • Over the past 5 years, vTv Therapeutics' Change in Cash (Quarter) stood at -$6.2 million in 2021, then surged by 47.76% to -$3.2 million in 2022, then surged by 137.6% to $1.2 million in 2023, then plummeted by 499.42% to -$4.8 million in 2024, then skyrocketed by 1604.29% to $72.6 million in 2025.
  • Its Change in Cash was $72.6 million in Q3 2025, compared to -$5.1 million in Q2 2025 and -$5.7 million in Q1 2025.